These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2989375)

  • 1. Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.
    Schröder JM; Kosfeld U; Christophers E
    J Invest Dermatol; 1985 Jul; 85(1):30-4. PubMed ID: 2989375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E; Schröder JM; Christophers E
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
    Senior RM; Skogen WF; Griffin GL; Wilner GD
    J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human monocyte functions by anthralin.
    Mrowietz U; Falsafi M; Schröder JM; Christophers E
    Br J Dermatol; 1992 Oct; 127(4):382-6. PubMed ID: 1329912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-Met-Leu-Phe.
    Spilberg I; Mehta J; Muniain MA; Simchowitz L; Atkinson J
    Inflammation; 1984 Mar; 8(1):73-86. PubMed ID: 6325345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding.
    Shelly J; Hoff SF
    Gen Pharmacol; 1989; 20(3):329-34. PubMed ID: 2545509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal or oxidation of surface membrane sialic acid inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong RR; Elfman F
    J Immunol; 1985 Mar; 134(3):1902-8. PubMed ID: 2981927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE; Zanolari B; Springer MS; Guindon Y; Zamboni R; Lau CK; Rokach J
    Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
    J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
    Feltner DE; Smith RH; Marasco WA
    J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen.
    Nielsen VG; Webster RO
    Immunopharmacology; 1987 Feb; 13(1):61-71. PubMed ID: 3032852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.